Ontology highlight
ABSTRACT: Background
Occipital-cervical fusion (OCF) and ventral decompression (VD) may be used in the treatment of pediatric Chiari-1 malformation (CM-1) with syringomyelia (SM) as adjuncts to posterior fossa decompression (PFD) for complex craniovertebral junction pathology.Objective
To examine factors influencing the use of OCF and OCF/VD in a multicenter cohort of pediatric CM-1 and SM subjects treated with PFD.Methods
The Park-Reeves Syringomyelia Research Consortium registry was used to examine 637 subjects with cerebellar tonsillar ectopia ≥ 5 mm, syrinx diameter ≥ 3 mm, and at least 1 yr of follow-up after their index PFD. Comparisons were made between subjects who received PFD alone and those with PFD + OCF or PFD + OCF/VD.Results
All 637 patients underwent PFD, 505 (79.2%) with and 132 (20.8%) without duraplasty. A total of 12 subjects went on to have OCF at some point in their management (PFD + OCF), whereas 4 had OCF and VD (PFD + OCF/VD). Of those with complete data, a history of platybasia (3/10, P = .011), Klippel-Feil (2/10, P = .015), and basilar invagination (3/12, P < .001) were increased within the OCF group, whereas only basilar invagination (1/4, P < .001) was increased in the OCF/VD group. Clivo-axial angle (CXA) was significantly lower for both OCF (128.8 ± 15.3°, P = .008) and OCF/VD (115.0 ± 11.6°, P = .025) groups when compared to PFD-only group (145.3 ± 12.7°). pB-C2 did not differ among groups.Conclusion
Although PFD alone is adequate for treating the vast majority of CM-1/SM patients, OCF or OCF/VD may be occasionally utilized. Cranial base and spine pathologies and CXA may provide insight into the need for OCF and/or OCF/VD.
SUBMITTER: CreveCoeur TS
PROVIDER: S-EPMC7803430 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
CreveCoeur Travis S TS Yahanda Alexander T AT Maher Cormac O CO Johnson Gabrielle W GW Ackerman Laurie L LL Adelson P David PD Ahmed Raheel R Albert Gregory W GW Aldana Phillipp R PR Alden Tord D TD Anderson Richard C E RCE Baird Lissa L Bauer David F DF Bierbrauer Karin S KS Brockmeyer Douglas L DL Chern Joshua J JJ Couture Daniel E DE Daniels David J DJ Dauser Robert C RC Durham Susan R SR Ellenbogen Richard G RG Eskandari Ramin R Fuchs Herbert E HE George Timothy M TM Grant Gerald A GA Graupman Patrick C PC Greene Stephanie S Greenfield Jeffrey P JP Gross Naina L NL Guillaume Daniel J DJ Haller Gabe G Hankinson Todd C TC Heuer Gregory G GG Iantosca Mark M Iskandar Bermans J BJ Jackson Eric M EM Jea Andrew H AH Johnston James M JM Keating Robert F RF Kelly Michael P MP Khan Nickalus N Krieger Mark D MD Leonard Jeffrey R JR Mangano Francesco T FT Mapstone Timothy B TB McComb J Gordon JG Menezes Arnold H AH Muhlbauer Michael M Oakes W Jerry WJ Olavarria Greg G O'Neill Brent R BR Park Tae Sung TS Ragheb John J Selden Nathan R NR Shah Manish N MN Shannon Chevis C Shimony Joshua S JS Smith Jodi J Smyth Matthew D MD Stone Scellig S D SSD Strahle Jennifer M JM Tamber Mandeep S MS Torner James C JC Tuite Gerald F GF Wait Scott D SD Wellons John C JC Whitehead William E WE Limbrick David D DD
Neurosurgery 20210101 2
<h4>Background</h4>Occipital-cervical fusion (OCF) and ventral decompression (VD) may be used in the treatment of pediatric Chiari-1 malformation (CM-1) with syringomyelia (SM) as adjuncts to posterior fossa decompression (PFD) for complex craniovertebral junction pathology.<h4>Objective</h4>To examine factors influencing the use of OCF and OCF/VD in a multicenter cohort of pediatric CM-1 and SM subjects treated with PFD.<h4>Methods</h4>The Park-Reeves Syringomyelia Research Consortium registry ...[more]